BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12189161)

  • 1. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells.
    Tao Q; Huang H; Geiman TM; Lim CY; Fu L; Qiu GH; Robertson KD
    Hum Mol Genet; 2002 Sep; 11(18):2091-102. PubMed ID: 12189161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome.
    Hansen RS; Wijmenga C; Luo P; Stanek AM; Canfield TK; Weemaes CM; Gartler SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14412-7. PubMed ID: 10588719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients.
    Tuck-Muller CM; Narayan A; Tsien F; Smeets DF; Sawyer J; Fiala ES; Sohn OS; Ehrlich M
    Cytogenet Cell Genet; 2000; 89(1-2):121-8. PubMed ID: 10894953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.
    Jin B; Tao Q; Peng J; Soo HM; Wu W; Ying J; Fields CR; Delmas AL; Liu X; Qiu J; Robertson KD
    Hum Mol Genet; 2008 Mar; 17(5):690-709. PubMed ID: 18029387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes.
    Ehrlich M; Buchanan KL; Tsien F; Jiang G; Sun B; Uicker W; Weemaes CM; Smeets D; Sperling K; Belohradsky BH; Tommerup N; Misek DE; Rouillard JM; Kuick R; Hanash SM
    Hum Mol Genet; 2001 Dec; 10(25):2917-31. PubMed ID: 11741835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and genetic manifestations of immunodeficiency, centromeric instability, and facial anomalies syndrome: a case report and literature review].
    Hu SC; Wang YB; Sun Q; Liu XR; Sun LL; Cui GM
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):55-59. PubMed ID: 30630233
    [No Abstract]   [Full Text] [Related]  

  • 7. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease.
    Ehrlich M
    Clin Immunol; 2003 Oct; 109(1):17-28. PubMed ID: 14585272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF).
    Ehrlich M; Jackson K; Weemaes C
    Orphanet J Rare Dis; 2006 Mar; 1():2. PubMed ID: 16722602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-random length distribution of individual telomeres in immunodeficiency, centromeric instability and facial anomalies syndrome, type I.
    Sagie S; Edni O; Weinberg J; Toubiana S; Kozlovski T; Frostig T; Katzin N; Bar-Am I; Selig S
    Hum Mol Genet; 2017 Nov; 26(21):4244-4256. PubMed ID: 28973513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide DNA Methylation Analysis Identifies Novel Hypomethylated Non-Pericentromeric Genes with Potential Clinical Implications in ICF Syndrome.
    Simo-Riudalbas L; Diaz-Lagares A; Gatto S; Gagliardi M; Crujeiras AB; Matarazzo MR; Esteller M; Sandoval J
    PLoS One; 2015; 10(7):e0132517. PubMed ID: 26161907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic alteration of microRNAs in DNMT3B-mutated patients of ICF syndrome.
    Gatto S; Della Ragione F; Cimmino A; Strazzullo M; Fabbri M; Mutarelli M; Ferraro L; Weisz A; D'Esposito M; Matarazzo MR
    Epigenetics; 2010 Jul; 5(5):427-43. PubMed ID: 20448464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA replication is altered in Immunodeficiency Centromeric instability Facial anomalies (ICF) cells carrying DNMT3B mutations.
    Lana E; Mégarbané A; Tourrière H; Sarda P; Lefranc G; Claustres M; De Sario A
    Eur J Hum Genet; 2012 Oct; 20(10):1044-50. PubMed ID: 22378288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Satellite 2 methylation patterns in normal and ICF syndrome cells and association of hypomethylation with advanced replication.
    Hassan KM; Norwood T; Gimelli G; Gartler SM; Hansen RS
    Hum Genet; 2001 Oct; 109(4):452-62. PubMed ID: 11702227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtelomeric methylation distinguishes between subtypes of Immunodeficiency, Centromeric instability and Facial anomalies syndrome.
    Toubiana S; Velasco G; Chityat A; Kaindl AM; Hershtig N; Tzur-Gilat A; Francastel C; Selig S
    Hum Mol Genet; 2018 Oct; 27(20):3568-3581. PubMed ID: 30010917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new and a reclassified ICF patient without mutations in DNMT3B and its interacting proteins SUMO-1 and UBC9.
    Kloeckener-Gruissem B; Betts DR; Zankl A; Berger W; Güngör T
    Am J Med Genet A; 2005 Jul; 136(1):31-7. PubMed ID: 15952214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Mutation in a Critical Region for the Methyl Donor Binding in DNMT3B Causes Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome (ICF).
    Rechavi E; Lev A; Eyal E; Barel O; Kol N; Barhom SF; Pode-Shakked B; Anikster Y; Somech R; Simon AJ
    J Clin Immunol; 2016 Nov; 36(8):801-809. PubMed ID: 27734333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in ICF syndrome: evidence for genetic heterogeneity.
    Wijmenga C; Hansen RS; Gimelli G; Björck EJ; Davies EG; Valentine D; Belohradsky BH; van Dongen JJ; Smeets DF; van den Heuvel LP; Luyten JA; Strengman E; Weemaes C; Pearson PL
    Hum Mutat; 2000 Dec; 16(6):509-17. PubMed ID: 11102980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D position of pericentromeric heterochromatin within the nucleus of a patient with ICF syndrome.
    Dupont C; Guimiot F; Perrin L; Marey I; Smiljkovski D; Le Tessier D; Lebugle C; Baumann C; Bourdoncle P; Tabet AC; Aboura A; Benzacken B; Dupont JM
    Clin Genet; 2012 Aug; 82(2):187-92. PubMed ID: 21554265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2.
    van den Boogaard ML; Thijssen PE; Aytekin C; Licciardi F; Kıykım AA; Spossito L; Dalm VASH; Driessen GJ; Kersseboom R; de Vries F; van Ostaijen-Ten Dam MM; Ikinciogullari A; Dogu F; Oleastro M; Bailardo E; Daxinger L; Nain E; Baris S; van Tol MJD; Weemaes C; van der Maarel SM
    Clin Genet; 2017 Oct; 92(4):380-387. PubMed ID: 28128455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells as a model for telomeric abnormalities in ICF type I syndrome.
    Sagie S; Ellran E; Katzir H; Shaked R; Yehezkel S; Laevsky I; Ghanayim A; Geiger D; Tzukerman M; Selig S
    Hum Mol Genet; 2014 Jul; 23(14):3629-40. PubMed ID: 24549038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.